{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-031419","form_type":"8-K","ticker":"EUDA","cik":"0001847846","company_name":"EUDA Health Holdings Ltd","filed_at":"2022-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.707421+00:00","generated_at":"2026-06-21T23:53:22.106689+00:00","sec_items":["5.07","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"8i Acquisition 2 shareholders approve EUDA Health business combination; 8.2M shares redeemed","bullets":["All proposals approved at Nov 10 special meeting: business combination, name change to EUDA Health Holdings, stock issuance, and director election.","8,195,770 ordinary shares tendered for redemption at $10.0837 per share (~74% of outstanding shares).","Shareholders may withdraw redemption requests until 5 p.m. ET on Nov 11, 2022.","Five directors elected; effective upon consummation of the Business Combination."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-031419","json":"https://secwatch.observer/filing/0001493152-22-031419.json","markdown":"https://secwatch.observer/filing/0001493152-22-031419.md","text":"https://secwatch.observer/filing/0001493152-22-031419.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847846/000149315222031419/0001493152-22-031419-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847846/000149315222031419/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T23:53:22.106689+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"090ace3067ebb6b2537561d68e1f9d7ddcf10880","claim":"EUDA Health Holdings Ltd shareholders approved To approve the transactions contemplated under the SPA. at the 2022-11-10 meeting.","evidence_excerpt":"PROPOSAL 1: To approve the transactions contemplated under the SPA. For Against Abstain Broker Non-Votes 8,314,452 1,030,751 24,192 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847846/000149315222031419/0001493152-22-031419-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"merger approval"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-11-10"}],"fact_type":"shareholder_vote"},{"claim_id":"7e03c17a218ecb6d76e9ca5576d624156a18b37e","claim":"EUDA Health Holdings Ltd shareholders approved To approve, for purposes of complying with applicable listing rules of the Nasdaq Global Market, the issuance of more than 20% of the issued and outstanding Ordinary Shares and the resulting change in control in connection with the Business Combination. at the 2022-11-10 meeting.","evidence_excerpt":"PROPOSAL 3: To approve, for purposes of complying with applicable listing rules of the Nasdaq Global Market (“Nasdaq”), the issuance of more than 20% of the issued and outstanding Ordinary Shares and the resulting change in control in connection with the Business Combination. For Against Abstain Broker Non-Votes 8,335,895 1,030,751 2,755 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847846/000149315222031419/0001493152-22-031419-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"merger approval"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-11-10"}],"fact_type":"shareholder_vote"},{"claim_id":"84cdc7ddf98455e62a288cb4cb2d23393da8a0e1","claim":"EUDA Health Holdings Ltd shareholders approved To vote to elect five directors effective upon consummation of the Business Combination. at the 2022-11-10 meeting.","evidence_excerpt":"PROPOSAL 4: To vote to elect five directors effective upon consummation of the Business Combination. Each of the director nominees received the following votes: Director Nominee Class For Withhold Wei Wen Kelvin Chen I 8,436,565 932,836 Thien Su Gerald Lim I 8,436,565 932,836 David Francis Capes I 8,436,565 932,836 Alfred Lim II 8,436,565 932,836 Kim Hing Chan II 8,436,565 932,836","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847846/000149315222031419/0001493152-22-031419-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-11-10"}],"fact_type":"shareholder_vote"},{"claim_id":"a8a399ab3b661212ffdd37819877dd1512ddae9f","claim":"EUDA Health Holdings Ltd shareholders approved To approve and adopt the following amendments and restatements of 8i amended and restated memorandum and articles of association: a) to amend the name of the combined company from \"8i Acquisition 2 Corp.\" to \"EUDA Health Holdings Limited\"; and b) to adopt the amended and restated memorandum and arti at the 2022-11-10 meeting.","evidence_excerpt":"PROPOSAL 2: To approve and adopt the following amendments and restatements of 8i amended and restated memorandum and articles of association: a) to amend the name of the combined company from “8i Acquisition 2 Corp.” to “EUDA Health Holdings Limited”; and For Against Abstain Broker Non-Votes 8,335,895 1,030,751 2,755 0 2 b) to adopt the amended and restated memorandum and articles of association of the combined company (the “Amended and Restated Memorandum and Articles of Association”). For Against Abstain Broker Non-Votes 8,335,895 1,030,751 2,755 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847846/000149315222031419/0001493152-22-031419-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-11-10"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}